The DOI matches its Crossref record.
Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy
Abstract
BACKGROUND Diabetic nephropathy (DN) is a frequent complication in patients with diabetes mellitus. To find improved intervention strategies in this disease, it is necessary to investigate the molecular mechanisms involved. To obtain more insight into processes that lead to DN, messenger RNA expression profiles of diabetic glomeruli and glomeruli from healthy individuals were compared. METHODS Two morphologically normal kidneys and 2 kidneys from patients with DN were used for the study. Glomerular RNA was hybridized in duplicate on Human Genome U95Av2 Arrays (Affymetrix, Santa Clara, CA). Several transcripts were tested further in independent patient groups and at the protein level by immunohistochemistry. RESULTS Ninety-six genes were upregulated in diabetic glomeruli, whereas 519 genes were downregulated. The list of overexpressed genes in DN includes aquaporin 1, calpain 3, hyaluronoglucosidase, and platelet/endothelial cell adhesion molecule. The list of downregulated genes includes bone morphogenetic protein 2, vascular endothelial growth factor (VEGF), fibroblast growth factor 1, insulin-like growth factor binding protein 2, and nephrin. A decrease in VEGF and nephrin could be validated at the protein level and also at the RNA level in renal biopsy specimens from 5 additional patients with diabetes. CONCLUSION Results of oligonucleotide microarray analyses on control and diabetic glomeruli are presented and discussed in their relation to vascular damage, mesangial matrix expansion, proliferation, and proteinuria. Our findings suggest that progression of DN might result from diminished tissue repair capability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Transcriptome Analysis of Human Diabetic Kidney Disease
Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011) · Diabetes · doi:10.2337/db10-1181 · Cited by 642
The single-cell transcriptomic landscape of early human diabetic nephropathy
Wilson, P. C., Wu, H., Kirita, Y., Uchimura, K., Ledru, N., Rennke, H. G., Welling, P. A., Waikar, S. S., & Humphreys, B. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908706116 · Cited by 539
Integrated Analysis of Transcriptomic and Proteomic Data
Haider, S., & Pal, R. (2013) · Current Genomics · doi:10.2174/1389202911314020003 · Cited by 431
Carnosine as a Protective Factor in Diabetic Nephropathy
Janssen, B., Hohenadel, D., Brinkkoetter, P., Peters, V., Rind, N., Fischer, C., Rychlik, I., Cerna, M., Romzova, M., de Heer, E., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2320 · Cited by 291
Self-citationMapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy
Fechete, R., Heinzel, A., Perco, P., Mönks, K., Söllner, J., Stelzer, G., Eder, S., Lancet, D., Oberbauer, R., Mayer, G., et al. (2011) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201000136 · Cited by 45
Metadata
- Authors
- Baelde, H. J., Eikmans, M., Doran, P. P., Lappin, D. W. P., de Heer, E., & Bruijn, J. A.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 43
- Issue
- 4
- Pages
- 636-650
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2000579954
- Cited by
- 197
- References
- 0
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. https://app.cochat.ai/papers/10.1053/j.ajkd.2003.12.028
- The paper
- Baelde, H. J., Eikmans, M., Doran, P. P., Lappin, D. W. P., de Heer, E., & Bruijn, J. A. (2004). Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2003.12.028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.